The global respiratory care devices market, valued at approximately US$ 22.2 billion in 2024, rose to around US$ 23.6 billion in 2025 and is projected to reach US$ 33.6 billion by 2030, growing at a CAGR of 7.3% from 2025 to 2030.
This growth trajectory is underpinned by an array of demographic, medical and environmental drivers. Increasing prevalence of respiratory disorders such as asthma, sleep apnea and chronic obstructive pulmonary disease (COPD) — caused in part by smoking, aging populations and escalating levels of air pollution — is boosting demand for respiratory support equipment. The heightened awareness of respiratory health and large-scale expenditure in ventilators, oxygen therapy and monitoring equipment during the COVID-19 pandemic further accelerated market momentum.
Key Market Drivers
Rising Burden of Respiratory Diseases
The growing incidence of respiratory ailments globally is a principal driver for the respiratory care devices market. Aging populations and lifestyle factors are increasing the number of patients needing chronic respiratory support. Devices such as non-invasive ventilators, oxygen concentrators and monitoring tools are in greater demand.
Environmental & Lifestyle Factors
Worsening air quality, rising tobacco use, increasing indoor and outdoor pollutant exposure and sedentary lifestyles contribute to the prevalence of respiratory conditions. These macro-environmental trends serve to expand the addressable market for respiratory care devices.
Technological Innovation & Digital Health Integration
Leading companies are investing heavily in R&D and forming strategic partnerships to develop advanced, portable, connected respiratory devices. For example, non-invasive ventilators, smart inhalers and CPAP/BiPAP units integrated with digital health platforms are increasingly available. These innovations enhance patient compliance, ease of use, and home-care applicability.
Growth in Emerging Markets & Home Care Expansion
Expanding healthcare infrastructure in emerging economies and the shift toward home care and remote monitoring support market growth. The momentum created during the pandemic also opened doors for increased adoption of respiratory devices in outpatient and home-based settings.
Competitive Landscape & Strategic Activities
Key players in the global respiratory care devices market include:
- Koninklijke Philips N.V. (Netherlands)
- Medtronic plc (Ireland/US)
- ResMed Inc. (US)
- Fisher & Paykel Healthcare Limited (New Zealand)
- Drägerwerk AG & Co. KGaA (Germany)
- GE Healthcare (US)
- Masimo Corporation (US)
These companies are employing strategies such as product innovation (e.g., portable ventilators, digital inhalers), geographic expansion, acquisitions and service-portfolio enhancements. Their aim: deliver user-friendly, connected respiratory solutions both in hospitals and home-care settings.
Company Spotlights
Koninklijke Philips N.V.
Philips is a global leader in respiratory care devices, especially through its portfolio of non-invasive ventilators, CPAP/BiPAP systems and home-oxygen therapy solutions. With a strategic focus on integrated care, Philips combines hardware with its AI-powered HealthSuite digital platform to offer connected solutions across both hospital and home settings. Despite past challenges (such as device recalls), Philips continues to launch new products and strengthen its market position — highlighting its resilience and innovation focus.
Medtronic plc
Medtronic is one of the largest medical-technology companies in the world, with operations in more than 150 countries. The firm’s Acute Care & Monitoring business unit (which includes respiratory and patient-monitoring systems) exemplifies its strategy of integrating monitoring, intervention and digital health. Although Medtronic has scaled back traditional ventilator manufacturing, the company remains a key player in hospital-based respiratory systems, acute monitoring and critical-care interventions. Their focus on R&D, supply-chain excellence and global reach positions them strongly in the respiratory care devices market.
Market Trends & Forecasts
Product Evolution & Connectivity
- The trend toward portable, user-friendly devices (e.g., home ventilators, smart inhalers) continues to grow.
- Integration of digital health platforms, remote monitoring, cloud connectivity and AI analytics enhances patient adherence and clinical outcomes.
- The shift towards non-invasive respiratory support is accelerating as care moves beyond hospitals to home settings.
Regional Growth Patterns
While North America remains the largest regional market — thanks to high healthcare spending, advanced infrastructure and early device adoption — the Asia Pacific region is expected to offer the strongest growth opportunities. Investments in healthcare infrastructure, expanding middle classes, rising respiratory-disease prevalence and increasing home-care adoption contribute to significant upside potential in the region.
Forecast Summary
The market value is stepping from ~US$23.6 billion in 2025 toward ~US$33.6 billion by 2030 at ~7.3% CAGR. Market segmentation by therapy (ventilators, PAP devices, oxygen concentrators, monitoring systems) shows broad demand across hospital and home-care settings.
Challenges & Market Risks
While prospects are positive, the respiratory care devices market does face headwinds:
- Regulatory and reimbursement complexity: Obtaining approvals, dealing with recalls and ensuring reimbursement for home devices remain demanding.
- High cost of advanced devices: While home care is growing, cost remains a barrier in low- and middle-income markets.
- Supply-chain vulnerabilities: Respiratory devices often require sophisticated parts (e.g., sensors, software) and complex manufacturing.
- Device recalls and safety concerns: Past large-scale recalls (e.g., sleep-apnea devices) have impacted brand reputation and regulatory scrutiny.
- Need for user adherence & training: For home-use devices, patient compliance remains a challenge; devices must be intuitive and supported with services.
Outlook & Strategic Implications
For healthcare providers, device manufacturers and investors, several strategic implications emerge:
- Home-care deployment: Given the shift toward outpatient and home care, companies should invest in user-friendly, connected respiratory devices and service models.
- Digital health integration: Device manufacturers that embed analytics, tele-monitoring and remote support will differentiate themselves.
- Emerging-market focus: Companies expanding into Asia Pacific, Latin America and other growth regions will capture new patient pools and unmet demand.
- Portfolio diversification: Players expanding beyond acute ventilators into PAP therapy, oxygen delivery, monitoring and smart inhalers can capture the full care-continuum opportunity.
- Regulatory vigilance: Robust quality-control, post-market surveillance and compliance frameworks will help mitigate recall risks and build trust.
Conclusion
The global respiratory care devices market is expanding steadily, driven by the convergence of rising respiratory-disease prevalence, environmental and lifestyle factors, technology innovation and the shift toward home-based and connected care. With a forecast to reach ~US$33.6 billion by 2030, device manufacturers and healthcare providers have a significant growth opportunity. By focusing on digital integration, home-care enablement, emerging markets and patient-centric design, industry participants can position themselves for success in this vital and evolving healthcare segment.